Kidney transplant biopsy

被引：0
作者：
Amann K. [1 ]
机构：
[1] Abteilung für Nephropathologie, Pathologisches Institut, Universität Erlangen-Nürnberg, Erlangen 91054
来源：
Der Nephrologe | 2010年 / 5卷 / 1期
关键词：
CNI-toxicity; Infection; Organ rejection; Percutaneous biopsy; Protocol biopsy; Renal transplantation; Transvenous biopsy; Zero biopsy;
D O I：
10.1007/s11560-009-0374-9
中图分类号：
学科分类号：
摘要：
Kidney biopsy has an important role in care and treatment of kidney transplant patients. It is by now a standard procedure used in early stages for determining deficient primary function rising creatinine levels. Kidney biopsy is needed during later disease stages in case of acute or continued creatinine rise and above all clinical symptoms such as recurring proteinuria or erythrocyturia. It is now also used intraoperatively (so-called zero biopsies) for assessing the success of a kidney transplant. Kidney biopsy has also proven particularly useful in light of the shrinking supply of donor organs and the resulting need to employ less than optimal transplant material under certain circumstances. So-called protocol biopsies are also done in many treatment centers, i.e. biopsies that are not urgently indicated but are used a certain time after transplantation to determine early subclinical rejection and changes indicating chronic organ damage. It also allows significant scientific research in kidney transplantation as a whole. © 2010 Springer-Verlag.
引用
收藏
页码：67 / 76
页数：9
相关论文
共 18 条
  • [1] Racusen L.C., Solez K., Colvin R.B., Bonsib S.M., Castro M.C., Cavallo T., Croker B.P., Demetris A.J., Drachenberg C.B., Fogo A.B., Furness P., Gaber L.W., Gibson I.W., Glotz D., Goldberg J.C., Grande J., Halloran P.F., Hansen H.E., Hartley B., Hayry P.J., Hill C.M., Hoffman E.O., Hunsicker L.G., Lindblad A.S., Marcussen N., Mihatsch M.J., Nadasdy T., Nickerson P., Olsen T.S., Papadimitriou J.C., Randhawa P.S., Rayner D.C., Roberts I., Rose S., Rush D., Salinas-Madrigal L., Salomon D.R., Sund S.
  • [2] Racusen L.C., Halloran P.F., Solez K., Banff 2003 meeting report: New diagnostic insights and standards, American Journal of Transplantation, 4, 10, pp. 1562-1566, (2004)
  • [3] Racusen L.C., Colvin R.B., Solez K., Mihatsch M.J., Halloran P.F., Campbell P.M., Cecka M.J., Cosyns J.P., Demetris A.J., Fishbein M.C., Fogo A., Furness P., Gibson I.W., Glotz D., Hayry P., Hunsickern L., Kashgarian M., Kerman R., Magil A.J., Montgomery R., Morozumi K., Nickeleit V., Randhawa P., Regele H., Seron D., Seshan S., Sund S., Trpkov K., Antibody-mediated rejection criteria - An addition to the Banff '97 classification of renal allograft rejection, American Journal of Transplantation
  • [4] Solez K., Colvin R.B., Racusen L.C., Sis B., Halloran P.F., Birk P.E., Campbell P.M., Cascalho M., Collins A.B., Demetris A.J., Drachenberg C.B., Gibson I.W., Grimm P.C., Haas M., Lerut E., Liapis H., Mannon R.B., Marcus P.B., Mengel M., Mihatsch M.J., Nankivell B.J., Nickeleit V., Papadimitriou J.C., Platt J.L., Randhawa P., Roberts I., Salinas-Madriga L., Salomon D.R., Seron D., Sheaff M., Weening J.J., Banff '05 meeting report: Differential diagnosis of chronic allograft injury and eliminati
  • [5] Solez K., Colvin R.B., Racusen L.C., Haas M., Sis B., Mengel M., Halloran P.F., Baldwin W., Banfi G., Collins A.B., Cosio F., David D.S.R., Drachenberg C., Einecke G., Fogo A.B., Gibson I.W., Glotz D., Iskandar S.S., Kraus E., Lerut E., Mannon R.B., Mihatsch M., Nankivell B.J., Nickeleit V., Papadimitriou J.C., Randhawa P., Regele H., Renaudin K., Roberts I., Seron D., Smith R.N., Valente M., Banff 07 classification of renal allograft pathology: Updates and future directions, American Journal o
  • [6] Mengel M., Sis B., Halloran P.F., SWOT analysis of Banff: Strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology, American Journal of Transplantation, 7, 10, pp. 2221-2226, (2007)
  • [7] Demetris A.J., Liver biopsy interpretation for causes of late liver allograft dysfunction, Hepatology, 44, 2, pp. 489-501, (2006)
  • [8] Drachenberg C.B., Odorico J., Demetris A.J., Arend L., Bajema I.M., Bruijn J.A., Cantarovich D., Cathro H.P., Chapman J., Dimosthenous K., Fyfe-Kirschner B., Gaber L., Gaber O., Goldberg J., Honsova E., Iskandar S.S., Klassen D.K., Nankivell B., Papadimitriou J.C., Racusen L.C., Randhawa P., Reinholt F.P., Renaudin K., Revelo P.P., Ruiz P., Torrealba J.R., Vazquez-Martul E., Voska L., Stratta R., Bartlett S.T., Sutherland D.E.R., Banff schema for grading pancreas allograft rejection: Working pr
  • [9] Cendales L.C., Kanitakis J., Schneeberger S., Burns C., Ruiz P., Landin L., Remmelink M., Hewitt C.W., Landgren T., Lyons B., Drachenberg C.B., Solez K., Kirk A.D., Kleiner D.E., Racusen L., The Banff 2007 working classification of skin-containing composite tissue allograft pathology, American Journal of Transplantation, 8, 7, pp. 1396-1400, (2008)
  • [10] Nickeleit V., Zeiler M., Gudat F., Al E., Histological characteristics of interstitial renal allograft rejection, Kidney Blood Press Res, 21, 2-4, pp. 230-232, (1998)
12